{"id":"tp-61315","type":"article-newspaper","title":"Regeneron and Alnylam Win FDA Approval for Livsayis in Adults","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/61315","datePublished":"2026-11-19T12:23:40.000Z","dateModified":"2026-11-19T12:23:40.000Z","language":"en","abstract":"The RNA therapeutic, identified as Livsayis (cemdisiran), was approved to treat adults with myasthenia gravis, a chronic autoimmune condition.","section":"Business","references":[]}